Dublin, Ireland (PRWEB) February 26, 2013
Research and Markets has announced the addition of the "Emerging Pharmaceutical Technologies - Stem Cells" report to their offering.
Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and treatments are wide-ranging, yet largely unproven at present.
Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector in order to understand future competitive threats.
The impact on drug discovery & development will impact the whole industry through a range of changes, from greater understanding of diseases to improved screening of drug candidates.
With R&D pipelines across the industry still under pressure, collaboration between academia, stem cell specialist companies, pharmaceutical companies and government & regulators is needed to ensure the smooth and rapid advancement of these technologies.
The report, Emerging Pharmaceutical Technologies - Stem Cells has been written to support corporate strategy, new product development, business development, and R&D teams through its analysis of the trends being seen and the innovations taking place in this fast moving area. This report will support the corporate strategies and key decisions being made in this area through its analysis, insights, case studies, and company profiles included.
Key Reasons to Purchase
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: R&D Applications
Chapter 3: Therapeutic Applications
Chapter 4: Company Focus
For more information visit http://www.researchandmarkets.com/research/tpln48/emerging
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716